Autoimmunity Contributes to the Severe Progression of COVID-19
Clinical trial NCT04967781 · COMPLETED
Trial details
- NCT number
- NCT04967781
- Sponsor
- Zhongnan Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-03-10
- Primary completion
- 2021-05-27
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.